AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Objectives Superb microvascular imaging (SMI) provides a more sensitive assessment of small vessels compared with power and colour Doppler ultrasonography (PDUS and CDUS). We aimed to investigate the ...

These findings may inform development of novel anticoagulants and optimize their use in targeted populations with stroke. In the present work, we leveraged large-scale human genetic data to address ...

At close: April 8 at 4:00:02 PM EDT ...

At close: April 4 at 5:39:16 PM GMT+2 ...

Please note, the data displayed for this chart reflects the title's midweek position only, peak positions on this chart also relate to midweek chart positions. Official Singles Chart Update data ...

2025-2026 Honors Flowcharts The academic maps serve as a guideline for planning courses along your journey to graduation. Students should meet with their academic advisors regularly to confirm their ...